Swift Quoted on Whether French Energy Company’s Billion Dollar Investment in Iran Will Spur US Investment
July 9, 2017
TheStreet
Partner Christopher Swift was quoted in a TheStreet article, “Total’s $1 Billion Iran Deal Isn’t Likely to Herald More Investment as Banks Balk,” which covered the likelihood of American and other foreign companies investing in Iran following French energy giant Total SA announcement of its $1 billion investment there.
Swift explained, “the default setting for U.S. companies or foreign companies that are U.S. owned when it comes to Iran is no, unless there is a good reason to get to yes.”
Swift explained, “the default setting for U.S. companies or foreign companies that are U.S. owned when it comes to Iran is no, unless there is a good reason to get to yes.”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.